In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs. / Bechthold, Elena; Grey, Lucie; Diamant, Emil; Schmidt, Judith; Steigerwald, Ruben; Zhao, Fabao; Hansen, Kasper B.; Bunch, Lennart; Clausen, Rasmus P.; Wünsch, Bernhard.

In: Biological Chemistry, Vol. 404, No. 4, 2023, p. 255-265.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Bechthold, E, Grey, L, Diamant, E, Schmidt, J, Steigerwald, R, Zhao, F, Hansen, KB, Bunch, L, Clausen, RP & Wünsch, B 2023, 'In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs', Biological Chemistry, vol. 404, no. 4, pp. 255-265. https://doi.org/10.1515/hsz-2022-0229

APA

Bechthold, E., Grey, L., Diamant, E., Schmidt, J., Steigerwald, R., Zhao, F., Hansen, K. B., Bunch, L., Clausen, R. P., & Wünsch, B. (2023). In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs. Biological Chemistry, 404(4), 255-265. https://doi.org/10.1515/hsz-2022-0229

Vancouver

Bechthold E, Grey L, Diamant E, Schmidt J, Steigerwald R, Zhao F et al. In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs. Biological Chemistry. 2023;404(4):255-265. https://doi.org/10.1515/hsz-2022-0229

Author

Bechthold, Elena ; Grey, Lucie ; Diamant, Emil ; Schmidt, Judith ; Steigerwald, Ruben ; Zhao, Fabao ; Hansen, Kasper B. ; Bunch, Lennart ; Clausen, Rasmus P. ; Wünsch, Bernhard. / In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs. In: Biological Chemistry. 2023 ; Vol. 404, No. 4. pp. 255-265.

Bibtex

@article{0798ffaba247430a8b889618d9926341,
title = "In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs",
abstract = "The GluN2C subunit exists predominantly, but not exclusively in NMDA receptors within the cerebellum. Antagonists such as UBP1700 and positive allosteric modulators including PYD-106 and 3-acylamino-2-aminopropionic acid derivatives such as UA3-10 ((R)-2-amino-3-{[5-(2-bromophenyl)thiophen-2-yl]carboxamido}propionic acid) represent promising tool compounds to investigate the role of GluN2C-containing NMDA receptors in the signal transduction in the brain. However, due to its high polarity the bioavailability and CNS penetration of the amino acid UA3-10 are expected to be rather low. Herein, three ester prodrugs 12a-c of the NMDA receptor glycine site agonist UA3-10 were prepared and pharmacokinetically characterized. The esters 12a-c showed higher lipophilicity (higher logD7.4 values) than the acid UA3-10 but almost the same binding at human serum albumin. The acid UA3-10 was rather stable upon incubation with mouse liver microsomes and NADPH, but the esters 12a-c were fast hydrolyzed to afford the acid UA3-10. Incubation with pig liver esterase and mouse serum led to rapid hydrolysis of the esters 12a-c. The isopropyl ester 12c showed a promising logD7.4 value of 3.57 and the highest stability in the presence of pig liver esterase and mouse serum. These results demonstrate that ester prodrugs of UA3-10 can potentially afford improved bioavailability and CNS penetration. ",
keywords = "3-acylamino-2-aminopropionic acid derivatives, GluN2C subtype-specific NMDA agonists, hydrolytic stability, in vitro ADME, physicochemical parameters, UA3-10",
author = "Elena Bechthold and Lucie Grey and Emil Diamant and Judith Schmidt and Ruben Steigerwald and Fabao Zhao and Hansen, {Kasper B.} and Lennart Bunch and Clausen, {Rasmus P.} and Bernhard W{\"u}nsch",
note = "Funding Information: Research funding: This work was supported by the Research Training Group “Chemical biology of ion channels (Chembion)” funded by the Deutsche Forschungsgemeinschaft (DFG) [GRK 2515/1], which is gratefully acknowledged. The authors acknowledge financial support from the National Institutes of Health [NS097536] to K.B.H. Publisher Copyright: {\textcopyright} 2022 Walter de Gruyter GmbH, Berlin/Boston.",
year = "2023",
doi = "10.1515/hsz-2022-0229",
language = "English",
volume = "404",
pages = "255--265",
journal = "Biological Chemistry",
issn = "1431-6730",
publisher = "De Gruyter",
number = "4",

}

RIS

TY - JOUR

T1 - In vitro ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugs

AU - Bechthold, Elena

AU - Grey, Lucie

AU - Diamant, Emil

AU - Schmidt, Judith

AU - Steigerwald, Ruben

AU - Zhao, Fabao

AU - Hansen, Kasper B.

AU - Bunch, Lennart

AU - Clausen, Rasmus P.

AU - Wünsch, Bernhard

N1 - Funding Information: Research funding: This work was supported by the Research Training Group “Chemical biology of ion channels (Chembion)” funded by the Deutsche Forschungsgemeinschaft (DFG) [GRK 2515/1], which is gratefully acknowledged. The authors acknowledge financial support from the National Institutes of Health [NS097536] to K.B.H. Publisher Copyright: © 2022 Walter de Gruyter GmbH, Berlin/Boston.

PY - 2023

Y1 - 2023

N2 - The GluN2C subunit exists predominantly, but not exclusively in NMDA receptors within the cerebellum. Antagonists such as UBP1700 and positive allosteric modulators including PYD-106 and 3-acylamino-2-aminopropionic acid derivatives such as UA3-10 ((R)-2-amino-3-{[5-(2-bromophenyl)thiophen-2-yl]carboxamido}propionic acid) represent promising tool compounds to investigate the role of GluN2C-containing NMDA receptors in the signal transduction in the brain. However, due to its high polarity the bioavailability and CNS penetration of the amino acid UA3-10 are expected to be rather low. Herein, three ester prodrugs 12a-c of the NMDA receptor glycine site agonist UA3-10 were prepared and pharmacokinetically characterized. The esters 12a-c showed higher lipophilicity (higher logD7.4 values) than the acid UA3-10 but almost the same binding at human serum albumin. The acid UA3-10 was rather stable upon incubation with mouse liver microsomes and NADPH, but the esters 12a-c were fast hydrolyzed to afford the acid UA3-10. Incubation with pig liver esterase and mouse serum led to rapid hydrolysis of the esters 12a-c. The isopropyl ester 12c showed a promising logD7.4 value of 3.57 and the highest stability in the presence of pig liver esterase and mouse serum. These results demonstrate that ester prodrugs of UA3-10 can potentially afford improved bioavailability and CNS penetration.

AB - The GluN2C subunit exists predominantly, but not exclusively in NMDA receptors within the cerebellum. Antagonists such as UBP1700 and positive allosteric modulators including PYD-106 and 3-acylamino-2-aminopropionic acid derivatives such as UA3-10 ((R)-2-amino-3-{[5-(2-bromophenyl)thiophen-2-yl]carboxamido}propionic acid) represent promising tool compounds to investigate the role of GluN2C-containing NMDA receptors in the signal transduction in the brain. However, due to its high polarity the bioavailability and CNS penetration of the amino acid UA3-10 are expected to be rather low. Herein, three ester prodrugs 12a-c of the NMDA receptor glycine site agonist UA3-10 were prepared and pharmacokinetically characterized. The esters 12a-c showed higher lipophilicity (higher logD7.4 values) than the acid UA3-10 but almost the same binding at human serum albumin. The acid UA3-10 was rather stable upon incubation with mouse liver microsomes and NADPH, but the esters 12a-c were fast hydrolyzed to afford the acid UA3-10. Incubation with pig liver esterase and mouse serum led to rapid hydrolysis of the esters 12a-c. The isopropyl ester 12c showed a promising logD7.4 value of 3.57 and the highest stability in the presence of pig liver esterase and mouse serum. These results demonstrate that ester prodrugs of UA3-10 can potentially afford improved bioavailability and CNS penetration.

KW - 3-acylamino-2-aminopropionic acid derivatives

KW - GluN2C subtype-specific NMDA agonists

KW - hydrolytic stability

KW - in vitro ADME

KW - physicochemical parameters

KW - UA3-10

U2 - 10.1515/hsz-2022-0229

DO - 10.1515/hsz-2022-0229

M3 - Journal article

C2 - 36427206

AN - SCOPUS:85143065552

VL - 404

SP - 255

EP - 265

JO - Biological Chemistry

JF - Biological Chemistry

SN - 1431-6730

IS - 4

ER -

ID: 330836907